4Pestotnik SL,Classen DC,Evans RS,et al.Prospective surveillance of imipenem/cilastatin use and associated seizures using a hospital information system[J].Ann Pharmacother,1993,27(4):497-501.
5Linden P.Safety profile of meropenem:an updated review of over 6,000 patients treated with meropenem[J].Drug Saf,2007,30(8):657-668.